Literature DB >> 18693035

Binding sites of the viral RNA element TAR and of TAR mutants for various peptide ligands, probed with LILBID: a new laser mass spectrometry.

Nina Morgner1, Hans-Dieter Barth, Bernhard Brutschy, Ute Scheffer, Sven Breitung, Michael Göbel.   

Abstract

A new laser-based mass spectrometry method, called laser induced liquid bead ion desorption (LILBID), was applied to investigate RNA:ligand interactions. As model system the HIV Tat:TAR transactivation complex and its binding behavior were analyzed. TARwt of HIV Type 1 and Type 2 and different artificial mutants were compared regarding their binding to Tat and different peptide ligands. Specific and nonspecific association to TAR was deduced, with the bulge being the well known specific binding site of TAR. In the case of triple arginine (RRR) as a nonspecific ligand, multiple electrostatic binding to TAR was found at higher concentration of RRR. This contrasted with the formation of only ternary complexes in competitive binding studies with TAR, Tat, and potential inhibitors. The fact that the stoichiometries of the complexes can be determined is a major advantage of MS methods over the widely applied fluorimetric methods. A quantitative evaluation of the spectra by a numeric model for ternary complex formation allows conclusions about the role and strength of the binding sites of the RNAs, the specificity and affinity of different ligands, the determination of apparent IC50 and KD values, and a comparison of the binding efficiencies of potential inhibitors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18693035     DOI: 10.1016/j.jasms.2008.07.001

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  25 in total

Review 1.  Targeting the HIV trans-activation responsive region--approaches towards RNA-binding drugs.

Authors:  Andreas Krebs; Verena Ludwig; Oliver Boden; Michael W Göbel
Journal:  Chembiochem       Date:  2003-10-06       Impact factor: 3.164

2.  Structural model of the HIV-1 Tat(46-58)-TAR complex.

Authors:  M J Seewald; A U Metzger; D Willbold; P Rösch; H Sticht
Journal:  J Biomol Struct Dyn       Date:  1998-12

Review 3.  Inhibitors of HIV-1 Tat-mediated transactivation.

Authors:  S N Richter; G Palù
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

4.  A novel approach to analyze membrane proteins by laser mass spectrometry: from protein subunits to the integral complex.

Authors:  Nina Morgner; Thomas Kleinschroth; Hans-Dieter Barth; Bernd Ludwig; Bernhard Brutschy
Journal:  J Am Soc Mass Spectrom       Date:  2007-04-29       Impact factor: 3.109

5.  Metal-free catalysts for the hydrolysis of RNA derived from guanidines, 2-aminopyridines, and 2-aminobenzimidazoles.

Authors:  Ute Scheffer; Andreas Strick; Verena Ludwig; Sascha Peter; Elisabeth Kalden; Michael W Göbel
Journal:  J Am Chem Soc       Date:  2005-02-23       Impact factor: 15.419

6.  Activity of synthetic peptides from the Tat protein of human immunodeficiency virus type 1.

Authors:  A D Frankel; S Biancalana; D Hudson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

7.  Structural rearrangements of HIV-1 Tat-responsive RNA upon binding of neomycin B.

Authors:  C Faber; H Sticht; K Schweimer; P Rösch
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

8.  Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA.

Authors:  K S Long; D M Crothers
Journal:  Biochemistry       Date:  1999-08-03       Impact factor: 3.162

Review 9.  RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA.

Authors:  John J Turner; Simon Jones; Martin M Fabani; Gabriela Ivanova; Andrey A Arzumanov; Michael J Gait
Journal:  Blood Cells Mol Dis       Date:  2006-11-17       Impact factor: 3.039

10.  TAR-RNA recognition by a novel cyclic aminoglycoside analogue.

Authors:  Devanathan Raghunathan; Víctor M Sánchez-Pedregal; Jochen Junker; Claudia Schwiegk; Markus Kalesse; Andreas Kirschning; Teresa Carlomagno
Journal:  Nucleic Acids Res       Date:  2006-07-19       Impact factor: 16.971

View more
  4 in total

1.  Cell-free expression and stable isotope labelling strategies for membrane proteins.

Authors:  Solmaz Sobhanifar; Sina Reckel; Friederike Junge; Daniel Schwarz; Lei Kai; Mikhail Karbyshev; Frank Löhr; Frank Bernhard; Volker Dötsch
Journal:  J Biomol NMR       Date:  2009-08-13       Impact factor: 2.835

2.  Mass spectrometric characterization of oligomers in Pseudomonas aeruginosa azurin solutions.

Authors:  Lucie Sokolová; Heather Williamson; Jan Sýkora; Martin Hof; Harry B Gray; Bernd Brutschy; Antonín Vlcek
Journal:  J Phys Chem B       Date:  2011-03-31       Impact factor: 2.991

3.  Native Top-Down Mass Spectrometry of TAR RNA in Complexes with a Wild-Type tat Peptide for Binding Site Mapping.

Authors:  Eva-Maria Schneeberger; Kathrin Breuker
Journal:  Angew Chem Int Ed Engl       Date:  2016-12-21       Impact factor: 15.336

4.  Didehydro-Cortistatin A Inhibits HIV-1 by Specifically Binding to the Unstructured Basic Region of Tat.

Authors:  Sonia Mediouni; Krishna Chinthalapudi; Mary K Ekka; Ippei Usui; Joseph A Jablonski; Mark A Clementz; Guillaume Mousseau; Jason Nowak; Venkat R Macherla; Jacob N Beverage; Eduardo Esquenazi; Phil Baran; Ian Mitchelle S de Vera; Douglas Kojetin; Erwann P Loret; Kendall Nettles; Souvik Maiti; Tina Izard; Susana T Valente
Journal:  mBio       Date:  2019-02-05       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.